-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Alaunos Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Alaunos Therapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$1.17M, a 85.4% increase year-over-year.
- Alaunos Therapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$19.5M, a 43.3% increase year-over-year.
- Alaunos Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$34.3M, a 2.39% increase from 2022.
- Alaunos Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$35.1M, a 54.7% increase from 2021.
- Alaunos Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$77.5M, a 3.5% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)